Fundraising Fox
Nanobiotix
Founded 2003 · 143 employees on LinkedIn · 7 known investors
Find your way into Nanobiotix
Sign up to see every warm intro you have to Nanobiotix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanobiotix team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
Investors · 7
How we know: Karista's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Seventure Partners's portfolio page · Not right? Tell us
How we know: stocktitan.net · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$100M disclosed across 1 round · 2026
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nanobiotix do?
- Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
- Who are Nanobiotix's investors?
- Nanobiotix's investors include CapDecisif Management, HEALTHCARE ROYALTY PARTNERS, Karista, Seventure Partners, Jefferies.
- How much funding has Nanobiotix raised?
- Nanobiotix has disclosed $100M raised across 1 round.